Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM172A - NOTCH antagonist SAHM1 effect on T-ALL cell lines
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM172A - Pediatric age-specific host response to septic shock: whole blood
FAM172A - Invasive ductal and lobular breast carcinomas
FAM172A - Stratification of pediatric septic shock patients: whole blood
FAM172A - Various stages of Alzheimer's disease: laser-captured hippocampal CA1 gray matter
FAM172A - Peptidyl-prolyl cis/trans isomerase Pin1 deficiency effect on prostate cancer cells
FAM172A - Turner syndrome amniocyte derived-induced pluripotent stem cells
FAM172A - Mesenchymal-to-amoeboid transition effect on Hs294T melanoma cells
FAM172A - Rheumatoid arthritic synovium response to tocilizumab
FAM172A - West Nile virus infection effect on retinal pigment epithelium cells
FAM172A - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
GEO DataSets Gene Chromosome neighbors Homologene neighbors
FAM172A - Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
FAM172A - Tendinopathy
FAM172A - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
FAM172A - First, second and third trimester pregnancy: maternal cell-free plasma
FAM172A - YAP transcriptional regulator depletion effect on endothelial cells
FAM172A - U373MG glioblastoma cell line response to 3 anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids
FAM172A - Stem cell factor SOX2-deficient stomach carcinoma cell line: time course
FAM172A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM172A - Saracatinib-sensitive versus -resistant, PIK3CA mutant colorectal cancer xenografts
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on